Back to top

Biogen receives EC approval for Zurzuvae

Biogen (BIIB) announced that the European Commission has granted marketing authorization for ZURZUVAE to treat post-partum depression in adults fol...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Biogen Inc. (BIIB)